Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.
P/S ratio for Dr. Lal PathLabs Limited (LALPATHLAB.NS)
P/S ratio as of 2023: 8.55
According to Dr. Lal PathLabs Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.55. At the end of 2022 the company had a P/S ratio of 7.51.
P/S ratio history for Dr. Lal PathLabs Limited from 2010 to 2023
P/S ratio at the end of each year
| Year | P/S ratio |
|---|---|
| 2023 | 8.55 |
| 2022 | 7.51 |
| 2021 | 10.34 |
| 2020 | 14.13 |
| 2019 | 8.68 |
| 2018 | 7.18 |
| 2017 | 6.75 |
| 2016 | 8.62 |
| 2015 | 9.59 |
| 2014 | 6.76 |
| 2013 | 12.22 |
| 2012 | 15.10 |
| 2011 | 19.92 |
| 2010 | 28.74 |